0000000000668662

AUTHOR

Francesca Mertan

showing 1 related works from this author

Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System

2017

The PI-RADS™ (Prostate Imaging Reporting and Data System), version 2 scoring system, introduced in 2015, is based on expert consensus. In the same time frame ISUP (International Society of Urological Pathology) introduced a new pathological scoring system for prostate cancer. Our goal was to prospectively evaluate the cancer detection rates for each PI-RADS, version 2 category and compare them to ISUP group scores in patients undergoing systematic biopsy and magnetic resonance imaging-transrectal ultrasound fusion guided biopsy.A total of 339 treatment naïve patients prospectively underwent multiparametric magnetic resonance imaging evaluated with PI-RADS, version 2 with subsequent systemat…

Image-Guided BiopsyMalemedicine.medical_specialtyPathologyUrology030232 urology & nephrology030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstateBiopsymedicineMedical imagingHumansProspective StudiesMultiparametric Magnetic Resonance ImagingAgedUltrasonographymedicine.diagnostic_testbusiness.industryProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenmedicine.anatomical_structureRadiologyNeoplasm GradingbusinessJournal of Urology
researchProduct